Despite looming tariffs, global pharma companies rely on Chinese biotech
Related Posts
Egypt’s human rights record to be examined by Universal Periodic Review
The human rights record of Egypt will be examined by the United Nations Human Rights Council’s Universal Periodic Review (UPR) Working Group for […]
Anglo American Writes Down De Beers by $2.9 Billion Amid Market Challenges
Anglo American has reduced the value of its diamond subsidiary, De Beers, by $2.9 billion, marking the second consecutive year of such writedowns. […]
Somalia: Statement by the Spokesperson on the latest terrorist attack on the Presidential convoy
The European Union strongly condemns yesterday’s terrorist attack in Mogadishu, which targeted the convoy of the President of the Federal Republic of Somalia, […]